Suggestions the US Food and Drug Administration’s standard application assessment may be losing relevance appear to have been premature.
In Fiscal Year 2022, the most recent data available, standard assessments reversed a widening gap from the number of
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?